|
|
PVCT Provectus Biopharmaceuticals
|
|
||
PerspectiveI compared today’s data to this study: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.9522 My take away is we had 32% partial response and no withdrawals from the study based on adverse events; the above P2 trial with ipi/nivo had 17% partial response and 29% were removed due to adverse events So...PV-10 combo is more effective and less toxic than big pharmas’ drugs Look for the company to obtain one year overall survival data and ask for BTD if above 70% |
return to message board, top of board |